Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A

Movement Disorders

Volumn 15, Issue 1, 2000, Pages 150-153

  Brashear, Allison ^a,b   Bergan, Kathleen ^a   Wojcieszek, Joanne ^a   Siemers, Eric R ^a   Ambrosius, Walter ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Botulinum toxin; Cervical dystonia; Torticollis

Indexed keywords

BOTULINUM TOXIN A; SPASMOLYTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPHAGIA; DYSTONIA; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PERCEPTION; PRIORITY JOURNAL; RASH;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PATIENT DROPOUTS; PATIENT SATISFACTION; TORTICOLLIS; TREATMENT OUTCOME;

EID: 0033981919     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200001)15:1<150::AID-MDS1024>3.0.CO;2-X     Document Type: Article

References (5)

1. Erbguth F, Claus D, Jaspert A, Druschky A, Neundorfer B. Which patients discontinue treatment with botulinum toxin in cervical dystonia? (Abstract) Mov Disord 1995;10:371.
2. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194.
3. Jankovic J. Botulinum toxin injections for cervical dystonia. Neurology 1990;40:277-280.
4. Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York, NY: Wiley, 1973.
5. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol 1. Lyon, France: International Agency for Research on Cancer, 1980.